Comparison of Oncologic Outcomes of Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (ddMVAC) with Gemcitabine and Cisplatin (GC) as Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Systematic Review and Meta-Analysis

SIMPLE SUMMARY: Currently, platinum-based neoadjuvant chemotherapy (NAC) is becoming a standard treatment for use in patients with muscle-invasive bladder cancer. However, comparisons of oncologic outcomes for the two most commonly used NAC regimens, ddMVAC (dose-dense methotrexate, vinblastine, dox...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Doo Yong, Kang, Dong Hyuk, Kim, Jong Won, Ha, Jee Soo, Kim, Do Kyung, Cho, Kang Su
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199668/
https://www.ncbi.nlm.nih.gov/pubmed/34199565
http://dx.doi.org/10.3390/cancers13112770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199668/
https://www.ncbi.nlm.nih.gov/pubmed/34199565
http://dx.doi.org/10.3390/cancers13112770

Ejemplares similares